EGFR/Met association regulates EGFR TKI resistance in breast cancer
about
The dynamic nature of the kinomeEGFR/HER-targeted therapeutics in ovarian cancerThe Under-Appreciated Promiscuity of the Epidermal Growth Factor Receptor FamilyDevelopmental therapeutics for inflammatory breast cancer: Biology and translational directionsMET Gene Amplification and MET Receptor Activation Are Not Sufficient to Predict Efficacy of Combined MET and EGFR Inhibitors in EGFR TKI-Resistant NSCLC CellsSrc family kinases mediate epidermal growth factor receptor signaling from lipid rafts in breast cancer cells.EGFR Tyrosine 845 Phosphorylation-Dependent Proliferation and Transformation of Breast Cancer Cells Require Activation of p38 MAPK.Cetuximab-induced MET activation acts as a novel resistance mechanism in colon cancer cells.Mechanisms of HGF/Met signaling to Brk and Sam68 in breast cancer progression.Redundant kinase activation and resistance of EGFR-tyrosine kinase inhibitors.Acquired resistance to drugs targeting receptor tyrosine kinasesp95HER2 truncated form in resected non-small cell lung cancerEGFR and c-Met Cross Talk in Glioblastoma and Its Regulation by Human Cord Blood Stem CellsEGFR Signaling Enhances Aerobic Glycolysis in Triple-Negative Breast Cancer Cells to Promote Tumor Growth and Immune Escape.Fibroblast-secreted hepatocyte growth factor mediates epidermal growth factor receptor tyrosine kinase inhibitor resistance in triple-negative breast cancers through paracrine activation of MetHER3 signalling is regulated through a multitude of redundant mechanisms in HER2-driven tumour cells.Pharmacokinetic-pharmacodynamic modeling of the antitumor effect of TM208 and EGFR-TKI resistance in human breast cancer xenograft miceRecently identified biomarkers that promote lymph node metastasis in head and neck squamous cell carcinomaCell Culture Models and Pharmacological Perspective for the Study of Breast Cancer MarkersRole of epidermal growth factor receptor in breast cancer.Met interacts with EGFR and Ron in canine osteosarcomacMET in triple-negative breast cancer: is it a therapeutic target for this subset of breast cancer patients?Differential roles of trans-phosphorylated EGFR, HER2, HER3, and RET as heterodimerisation partners of MET in lung cancer with MET amplification.EGFR targeted therapies and radiation: Optimizing efficacy by appropriate drug scheduling and patient selection.HER2 and EGFR Overexpression Support Metastatic Progression of Prostate Cancer to Bone.MET is a potential target for use in combination therapy with EGFR inhibition in triple-negative/basal-like breast cancer.γ-Tocotrienol inhibits HGF-dependent mitogenesis and Met activation in highly malignant mammary tumour cells.Acquired MET expression confers resistance to EGFR inhibition in a mouse model of glioblastoma multiforme.Multiplexed Exchange-PAINT imaging reveals ligand-dependent EGFR and Met interactions in the plasma membrane.A c-Jun N-terminal kinase inhibitor, JNK-IN-8, sensitizes triple negative breast cancer cells to lapatinib.A Novel Signaling Complex between TROY and EGFR Mediates Glioblastoma Cell Invasion.Acquired Resistance to Drugs Targeting Tyrosine Kinases.The Role of PI3K in Met Driven Cancer: A RecapAnti‑breast cancer activity of selected 1,3,5‑triazines via modulation of EGFR‑TKCombination of EGFR Inhibitor Lapatinib and MET Inhibitor Foretinib Inhibits Migration of Triple Negative Breast Cancer Cell Lines
P2860
Q26852588-D1EB8588-B3F5-4865-A5DE-EB12E1722EA5Q26863231-8B95564F-4FB6-4D33-B3DC-53DB9ABF0F43Q28073335-EAD2A9F8-32A7-4EAE-90C8-6A81EFC02F8AQ28075322-85DC45E6-C2FF-4B34-833B-576A47C52AFDQ28551045-33C0332E-C821-406D-9637-FE83A91EA52BQ30424531-477C6FFD-3CAE-403B-A304-629FFD1C4E70Q30424563-C5B53E3B-18EF-49ED-9592-F7D6896F9664Q33580500-EF0D2DC3-D08D-4012-8ADC-0B26EE6DFE9AQ34085432-C7FE3824-1CC0-45B4-A8AC-822BCA3572B4Q34704781-406D178F-A81D-44A9-B679-20F6A219F7B6Q35823437-E9281BFB-F3F9-41D2-B79E-19D638677EC1Q36170889-2141AB9B-A52E-4C6A-AC60-74D518306DEAQ36310662-91393A80-72E7-4E5F-9FA4-7E51340C77F4Q36642685-3C2F72CD-8E72-4407-B79C-9A9EEC2CC91CQ36924414-7354D33B-10CE-4DE5-9733-0FF6ECE09C88Q37044197-475ADA5E-748A-4681-A62B-F90347D27A2BQ37112320-9096E487-C403-4EF5-9D1F-3E0339055C00Q37129819-1A0F7409-6DA5-42B2-B6B8-57D66D60F3B7Q37155008-4FC2F889-3523-45B3-95C3-9E0B62F32275Q37320346-76E4856A-63C7-4C4E-8645-4EFC8147F116Q37672081-85EDA4DA-3543-4B5F-8568-E8BC6CDA9DE6Q38236096-E4221CD3-4451-4F98-A7D1-8B8D1B433DB2Q38370754-047AE685-5CFF-4624-91A8-1670AE0EC5CCQ38552978-D096DC95-F76C-4047-B3AD-7FB76EB42BC4Q38735527-3F20E082-DD5D-4930-86AD-093FB4B9D266Q39016645-79C220FA-6A06-4CAF-8750-92D3F3A555FAQ39463034-78C66E7D-83A1-4307-BB11-D1B148D1BAAAQ41816118-B7AE3ECF-D45C-43AC-8BE8-CD1397C1AA57Q42172907-1EAE87A7-7EF6-4C3F-A019-471EAD5A4C61Q47113193-B07172D9-E28E-46A5-B798-493588E67239Q47979201-EA9492E3-F981-4E59-8B17-DBB2BE0B774BQ53701267-0E344CB6-3AB7-461C-9C74-E1D198BCD67AQ58566840-027E6528-88BC-473E-9BAC-EDE95CB9D468Q58703557-72540FD0-1ED0-476D-A209-81CDFCA49F35Q58730323-2DEB5342-75EE-4552-BD81-C46F40F033F7
P2860
EGFR/Met association regulates EGFR TKI resistance in breast cancer
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
EGFR/Met association regulates EGFR TKI resistance in breast cancer
@ast
EGFR/Met association regulates EGFR TKI resistance in breast cancer
@en
EGFR/Met association regulates EGFR TKI resistance in breast cancer
@en-gb
EGFR/Met association regulates EGFR TKI resistance in breast cancer
@nl
type
label
EGFR/Met association regulates EGFR TKI resistance in breast cancer
@ast
EGFR/Met association regulates EGFR TKI resistance in breast cancer
@en
EGFR/Met association regulates EGFR TKI resistance in breast cancer
@en-gb
EGFR/Met association regulates EGFR TKI resistance in breast cancer
@nl
prefLabel
EGFR/Met association regulates EGFR TKI resistance in breast cancer
@ast
EGFR/Met association regulates EGFR TKI resistance in breast cancer
@en
EGFR/Met association regulates EGFR TKI resistance in breast cancer
@en-gb
EGFR/Met association regulates EGFR TKI resistance in breast cancer
@nl
P2093
P2860
P3181
P356
P1476
EGFR/Met association regulates EGFR TKI resistance in breast cancer
@en
P2093
Julie L Boerner
Kelly L Mueller
Ramsi Haddad
Stephen P Ethier
Zeng-Quan Yang
P2860
P3181
P356
10.1186/1750-2187-5-8
P407
P577
2010-07-12T00:00:00Z